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Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus-associated disease (PCVAD) in the global pig population. PCVAD is considered as an emerging disease, and the incidence of this disease has increased dramatically over the past years. The prevalence of PCVAD in nursery pigs is 22.3% [5] . The symptoms of PCVAD include rapid weight loss, labored breathing, diarrhea, enlarged lymph nodes, skin and kidney lesions, jaundice, high mortality, and spontaneous abortion, among others. PCV2a and PCV2b are the two major pathogenic genotypes of PCV2. Currently, five commercial vaccines targeting PCV2a are available on the international market to control PCVAD [6] . However, epidemiological data show a global shift during the past 10 years from PCV2a to PCV2b as the main PCV2 genotype [7] . In China, this shift is associated with more severe PCVAD [8] .
The PCV2 genome has two major open reading frames (ORFs). ORF2 encodes the capsid protein (CP), which contains the major antigenic domains of PCV2 [9] . The recombinant CP of PCV2 expressed in the Escherichia coli was able to self-assemble into VLPs under certain favorable conditions [10] . The assembled VLPs could induce humoral, cell-mediated immunity and protection against PCVAD [11] . Frequently, during the production of VLPs, disassembly and reassembly (D/R) treatment were employed to improve VLP immunoreactivity, homogeneity and stability by exposing more conformational epitopes [12, 13] . To ensure the consistent and efficient production of PCV2b VLPs, real-time monitoring of the D/R of the CP is required. Conventionally, enzymelinked immunosorbent assays (ELISAs), size exclusion chromatography, dynamic light scattering, transmission electron microscopy (TEM), and analytical ultracentrifugation are used to monitor the VLP D/R [14, 15] . These methods require special instrumentation and prolonged processing. We tried to develop a simpler method for monitoring the assembly of PCV2b VLPs based on fluorescence spectroscopic analysis (FSA). By analyzing the different frequencies of light emitted during fluorescent spectroscopy, along with their relative intensities, the structure of the samples can be determined. This method is typically coupled with high-performance liquid chromatography to analyze organic compounds [16] .
Here, in pursuing a potential PCV2b VLP vaccine, we synthesized the gene coding for the CP of the PCV2b strain that is currently epidemic in China [8] , and expressed this CP in E. coli . We then tested the feasibility of using FSA for monitoring the assembly/disassembly (A/D) of PCV2b VLPs.
Based on the PCV2b amino acid sequence deposited in GenBank (No. AAT97647.1), the encoding gene of the CP of the PCV2b strain was synthesized by overlapping PCR, as previously described [17] . Then, a pET28a plasmid carrying the gene encoding CP was transformed into E.coli BL21 (DE3). A His-tag was added to either side of the CP gene. The CP-His (240 amino acids) was expressed in the E. coli . The cell lysate was then loaded onto a nickel affinity column (Pharmacia Biotech). Color version available online m M Tris, 500 m M NaCl, 500 m M imidazole, 50 m M β-mercaptoethanol, 5% glycerol, 0.05% Tween 80, pH 8.0). The eluted proteins were analyzed by SDS-PAGE, Western blotting and TEM. As shown in figure 1 , a protein with the molecular size of 28.9 kDa was induced by IPTG in the E. coli expressing our constructed CP-His gene ( fig. 1 a) . SDS-PAGE showed that most of the proteins from the sonicated E. coli were in the supernatant, suggesting that the protein is in a soluble form. The protein was then further purified by Ni chromatography and was recognized by Western blotting using the anti-PCV2b specific antibody and the 6× His-tag monoclonal antibody ( fig. 1 b) . The purified CP-His was separately diluted to a final concentration of 200 μg/ml using dialyzed buffers, and then examined under TEM at an accelerating voltage of 80 kV and photographed at a magnification of 40,000×. We found that no VLPs were assembled from the untreated purified proteins ( fig. 1 c) .
To form VLPs, the purified CP-His was dialyzed against buffer A (50 m M Na 2 that CP-His dialyzed against buffer A were assembled into homogeneous VLPs (VLP-A) with a diameter size of around 20 nm ( fig. 2 a) . Compared with VLP-A, VLP-C and VLP-B were progressively less homogeneous and less compact ( fig. 2 b, c) . These results indicate that the pH and the composition of dialysis buffer are crucial for VLP assembly. The addition of glycerol and PEG 6000 to the dialysis buffer may hinder the PCV2b VLP assembly. A pH of 6.5 is more favorable for PCV2b VLP assembly. Coincidently, PH 6.5 is the most optimal pH for the effective assembly of HPV16-L1 VLPs [18, 19] . We speculate that this is because pH 6.5 mimics the condition in the endoplasmic reticulum and Golgi apparatus, where the CP is physiologically self-assembled during the virus life cycle in mammals [12] . VLP-A could be fully disassembled in PBS containing 8 M urea and 5% β-mercaptoethanol after 12 h of incubation at 4 ° C ( fig. 2 d) .
A major point for this study was to test whether the A/D of CP-His could be monitored by FSA. VLP-A, VLP-B, VLP-C, and disassembled VLP were diluted in PBS to a concentration of 200 μg/ml, and then added into a 96-well FLUOTRAC 200 black immunology plate (Greiner Bio-One, Germany). Based on the previous reports [18] , the fluorescence emission peak of the assembled HPV VLPs appeared around 350 nm. Under the excitation wavelength of 280 nm, we measured the emission spectroscopy (310-400 nm) of the samples using a Synergy H1 Hybrid Microplate Reader (BioTek, USA). As shown in figure 2 e, an intense fluorescence signal was detected in the wells with assembled VLP-A, VLP-B, and VLP-C, but not in the wells with the disassembled VLPs. The fluorescent signals showed a curve with a peak at 320 nm, indicating the formation of the PCV2b VLPs. Noticeably, VLP-A, which was the most homogeneously assembled, showed more intense fluorescence signals than VLP-B or VLP-C. To determine whether there was a correlation between the fluorescence signal strength and the amount of assembled VLP, the assembled VLP-C was diluted into several concentrations and their fluorescence signals were detected. As shown in figure 2 f, the signal from the assembled VLP at a concentration of 50 μg/ml was readily detected, and the signal strength was weaker as the concentration of VLP was reduced. These findings demonstrated that the FSA could be universally employed to monitor the assembly of VLPs for a broad spectrum of viruses and that the fluorescence intensity reflects the quality of the assembled VLPs. Theoretically, the required condition for generating fluorescence is the existence of defined structures, like a conjugated double bond, which are capable of absorbing excitation light. For a folded protein, most of the fluorescence is from individual aromatic residues (e.g. tryptophan, tyrosine, and phenylalanine) and from their conjugated double bonds. Additionally, disulfide bonds also have an appreciable absorption in a defined wavelength range [20, 21] . Compared with the unfolded state, the folded, assembled VLPs have more disulfide bonds, conjugated double bonds, and other intermolecular forces, all of which can increase the intensity of the overall fluorescence of the VLP. Importantly, the simplicity of the method could make FSA a convenient tool for monitoring the A/D of VLPs.
Next, the immunogenicity of each of the PCV2b VLPs (VLP-A, VLP-B, and VLP-C) was assessed by an ELISA using a PCV2b polyclonal antibody that recognizes the conformational epitope on the VLP. Microplates coated with PCV2b VLPs (1 μg/well) were incubated with the 1: 50 dilutions of sera from mice immunized with inactivated PCV2b or from naïve mice. As shown in figure 3 , all three VLPs were recognized by the sera from the mice immunized with the formaldehyde-inactivated PCV2b, but not by the sera from the PCV2b-naïve mice, indicating that all three VLPs exposed the epitope on the surface of the VLP. Compared with VLP-B and VLP-C, VLP-A could bind to the anti-PCV2b antibody with the highest OD 492 value (exceeding 1.0), indicating that VLP-A could better expose the conformational epitope on its surface and possess the strongest immunogenicity. This result is correlated with the TEM images showing that the VLP-A is also the most homogeneously assembled. It has previously been reported that the assembled HPV-16 L1 VLP could be completely denatured by treatment with β-mercaptoethanol, a reducing agent, and that the denaturation could be detected by FSA [22] . To test whether this technique could also work for monitoring the disassembly of PCV2b VLPs, we similarly incubated the assembled VLPs with β-mercaptoethanol (5%, v/v) in PBS for 1, 3, 6, 12, 24, and 48 h at 4 ° C. Alternately, the assembled PCV2b CP VLP-Cs was incubated with β-mercaptoethanol (5%, v/v) combined with urea (8 M ) in PBS. The treated samples were analyzed by FSA. The FSA results showed that, unlike the previously reported HPV-16 L1 VLP, β-mercaptoethanol treatment could only partially disassemble the PCV2b VLP ( fig. 4 a) . In contrast, the VLPs treated with both β-mercaptoethanol and urea did not produce any fluorescence and were completely disassembled ( fig. 4 b) . The results suggest that other amino acids in addition to cysteine also contribute to the assembly of VLPs. This idea is supported by the finding that PCV2b CP with a Cys108 substitution mutant (CapC/S) formed irregular VLPs while N-terminal deleted PCV2b CP (Cap51-233) and the internal deletion mutant (CapΔ51-103) of PCV2b CP failed to form VLPs [11] . The data indicate that the sole cysteine residue in the PCV2b CP is not essential for forming PCV VLPs but plays an important role in the integrity of PCV VLPs.
In this study, we used FSA to monitor the A/D of PCV2b VLPs and showed that the quality of VLP assembly can be measured by fluorescence intensity. This method could be used for in-process analysis and quality control during the manufacture of PCV2b VLPs, as well as other VLPs. Additionally, among the three VLPs assembled using different buffer conditions, VLP-A showed the strongest antigenicity and is the most promising candidate antigen to be developed into an effective VLP vaccine for PCV.
